Open Access
Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment
Federica De Leo
1, 2, 3
,
Giacomo Quilici
1
,
Mario Tirone
2
,
Francesco De Marchis
3
,
Valeria Mannella
1, 4
,
Chiara Zucchelli
1
,
Alessandro Preti
5
,
Alessandro Gori
6
,
Maura Casalgrandi
5
,
Rosanna Mezzapelle
3
,
Marco E. Bianchi
2, 3
,
Giovanna Musco
1
5
HMGBiotech S.r.l. Milan Italy
|
6
Istituto di Chimica del Riconoscimento Molecolare CNR Milan Italy
|
Publication type: Journal Article
Publication date: 2019-08-14
scimago Q1
wos Q1
SJR: 2.756
CiteScore: 10.1
Impact factor: 6.2
ISSN: 1469221X, 14693178
PubMed ID:
31418171
Biochemistry
Molecular Biology
Genetics
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Frontiers in Immunology
4 publications, 11.11%
|
|
|
Journal of Medicinal Chemistry
2 publications, 5.56%
|
|
|
Cellular and Molecular Immunology
1 publication, 2.78%
|
|
|
F1000Research
1 publication, 2.78%
|
|
|
Journal of Microbiology
1 publication, 2.78%
|
|
|
Arteriosclerosis, Thrombosis, and Vascular Biology
1 publication, 2.78%
|
|
|
Experimental Biology and Medicine
1 publication, 2.78%
|
|
|
Cells
1 publication, 2.78%
|
|
|
Frontiers in Chemistry
1 publication, 2.78%
|
|
|
Translational Psychiatry
1 publication, 2.78%
|
|
|
Cellular and Molecular Neurobiology
1 publication, 2.78%
|
|
|
Cellular and Molecular Life Sciences
1 publication, 2.78%
|
|
|
Molecular Medicine
1 publication, 2.78%
|
|
|
Molecular Therapy - Nucleic Acids
1 publication, 2.78%
|
|
|
Journal of Cellular Physiology
1 publication, 2.78%
|
|
|
Methods in Enzymology
1 publication, 2.78%
|
|
|
International Journal of Molecular Sciences
1 publication, 2.78%
|
|
|
FEBS Open Bio
1 publication, 2.78%
|
|
|
Nature Reviews Urology
1 publication, 2.78%
|
|
|
Cancer Letters
1 publication, 2.78%
|
|
|
Nature Communications
1 publication, 2.78%
|
|
|
Fiziolohichnyĭ zhurnal
1 publication, 2.78%
|
|
|
Expert Opinion on Therapeutic Patents
1 publication, 2.78%
|
|
|
Medicine (United States)
1 publication, 2.78%
|
|
|
Journal of Clinical Medicine
1 publication, 2.78%
|
|
|
Journal of Molecular Liquids
1 publication, 2.78%
|
|
|
Computational and Structural Biotechnology Journal
1 publication, 2.78%
|
|
|
Trends in Biochemical Sciences
1 publication, 2.78%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
1 publication, 2.78%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Springer Nature
8 publications, 22.22%
|
|
|
Elsevier
7 publications, 19.44%
|
|
|
Frontiers Media S.A.
5 publications, 13.89%
|
|
|
MDPI
3 publications, 8.33%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 5.56%
|
|
|
Wiley
2 publications, 5.56%
|
|
|
American Chemical Society (ACS)
2 publications, 5.56%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 5.56%
|
|
|
F1000 Research
1 publication, 2.78%
|
|
|
Han-Gug Misaengmul Hag-hoe/The Microbiological Society of Korea
1 publication, 2.78%
|
|
|
SAGE
1 publication, 2.78%
|
|
|
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
1 publication, 2.78%
|
|
|
Taylor & Francis
1 publication, 2.78%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
36
Total citations:
36
Citations from 2024:
12
(33.33%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
De Leo F. et al. Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment // EMBO Reports. 2019. Vol. 20. No. 10.
GOST all authors (up to 50)
Copy
De Leo F., Quilici G., Tirone M., De Marchis F., Mannella V., Zucchelli C., Preti A., Gori A., Casalgrandi M., Mezzapelle R., Bianchi M. E., Musco G. Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment // EMBO Reports. 2019. Vol. 20. No. 10.
Cite this
RIS
Copy
TY - JOUR
DO - 10.15252/embr.201947788
UR - https://doi.org/10.15252/embr.201947788
TI - Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment
T2 - EMBO Reports
AU - De Leo, Federica
AU - Quilici, Giacomo
AU - Tirone, Mario
AU - De Marchis, Francesco
AU - Mannella, Valeria
AU - Zucchelli, Chiara
AU - Preti, Alessandro
AU - Gori, Alessandro
AU - Casalgrandi, Maura
AU - Mezzapelle, Rosanna
AU - Bianchi, Marco E.
AU - Musco, Giovanna
PY - 2019
DA - 2019/08/14
PB - European Molecular Biology Organization
IS - 10
VL - 20
PMID - 31418171
SN - 1469-221X
SN - 1469-3178
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_De Leo,
author = {Federica De Leo and Giacomo Quilici and Mario Tirone and Francesco De Marchis and Valeria Mannella and Chiara Zucchelli and Alessandro Preti and Alessandro Gori and Maura Casalgrandi and Rosanna Mezzapelle and Marco E. Bianchi and Giovanna Musco},
title = {Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment},
journal = {EMBO Reports},
year = {2019},
volume = {20},
publisher = {European Molecular Biology Organization},
month = {aug},
url = {https://doi.org/10.15252/embr.201947788},
number = {10},
doi = {10.15252/embr.201947788}
}